GOLDMAN SACHS GROUP INC - GEMPHIRE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 12 filers reported holding GEMPHIRE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$362,000
+52.1%
35,505
+17.1%
0.00%–
Q4 2016$238,000
-35.5%
30,319
-10.3%
0.00%–
Q3 2016$369,000–33,789–0.00%–
 Download
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q3 2016.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders